Researchers at Mayo Clinic have found that genetic variations could explain why some people with depression respond better to a certain treatment. David Mrazek, M.D., chair of the Mayo Clinic Department of Psychiatry and Psychology and senior author of this new study, comments why the findings are important for patients.
Dr. Mrazek discusses pharmacogenetics:
Dr. Mrazek addresses the genetic testing and its possible future:
